Pseudoephedrine Hcl Tablet, Extended Release
Product Images NDC 58602-804

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Pseudoephedrine Hcl (NDC 58602-804). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (120 mg, Blister Carton 20 (2 X 10) Extended-Release Tablets)

Package Label-principal Display Panel (120 mg, Blister Carton 20 (2 X 10) Extended-Release Tablets)
This is a drug label for a nasal decongestant containing pseudoephedrine HCl. The drug is intended to relieve nasal congestion and sinus pressure. The label includes warnings such as not to take the drug if you are currently taking certain antidepressants, have heart disease or an enlarged prostate gland. The drug is not intended for children under 2 years old. The label includes information about inactive ingredients, storage instructions, and a contact number for questions or comments. The drug is distributed by Aurohealth LLC and code TSDRUGS/22/2009.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.